Protective potential of piroxicam on human peripheral blood mononuclear cells against the suppressive capacity of glioblastoma cell lines

Dexamethasone, a common medication used in the treatment regimen of glioblastoma, has broad inhibitory effects on the immune responses. Here, in an in vitro study, we examined the effects of piroxicam, a potent substitute for dexamethasone, on peripheral blood mononuclear cells (PBMCs) co-cultured w...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdesheikhi, Jahangir, Sedghy, Farnaz, Farsinejad, Alireza, Mahmoudi, Merat, ranjkesh, Mahdi, Ahmadi-Zeidabadi, Meysam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672323/
https://www.ncbi.nlm.nih.gov/pubmed/36396965
http://dx.doi.org/10.1038/s41598-022-24392-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672323/
https://www.ncbi.nlm.nih.gov/pubmed/36396965
http://dx.doi.org/10.1038/s41598-022-24392-2

Ejemplares similares